Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Clinical features and outcomes in patients with extraskeletal Ewing sarcoma.

  • Read more about Clinical features and outcomes in patients with extraskeletal Ewing sarcoma.

Ethnic and racial differences in patients with Ewing sarcoma.

  • Read more about Ethnic and racial differences in patients with Ewing sarcoma.

Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort.

  • Read more about Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort.

Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.

  • Read more about Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.

TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.

  • Read more about TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.

Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.

  • Read more about Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.

High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma.

  • Read more about High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma.

Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients.

  • Read more about Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients.

Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

  • Read more about Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

  • Read more about International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

Pagination

  • Previous page ‹‹
  • Page 3
  • Next page ››
Subscribe to Cancer

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List